Sotera Health (SHC)
The price, the headline numbers and the latest news, in one place.
Sotera Health (SHC) Stock Price, Analysis & Data
| Bid | 17.97 |
| Market Cap | 5.58B |
| Revenue (ttm) | 1.22B |
| Net Income (ttm) | 163.48M |
| 1.77 | |
| 0.57 | |
| 34.29 | |
| 18.18 | |
| P/B (ttm) | 8.38 |
| P/S (ttm) | 4.59 |
| Earnings Date | Nov 3, 2026 |
| Ask | 20.75 |
| Volume | 1,684,361 |
| Avg. Volume (20D) | 2,864,933 |
| Open | 19.24 |
| Previous Close | 19.17 |
| Day's Range | 19.11 - 19.56 |
| 52-Week Range | 13.09 - 19.85 |
| Analyst | n/a |
| Price Target | 22.5 (15.33%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SHC
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for...
Financial Performance
In 2025, Sotera Health's revenue was 1.16B, an increase of 5.74% compared to the previous year's 1.1B. Earnings were 77.95M, an increase of 75.57%.
Financial StatementsAnalyst Forecast
According to 9 analyst ratings, the average rating for SHC stock is "null". The 12-month stock price forecast is 22.5, which is upside of 15.33% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $321.38M misses estimates by $0, with 9.18% YoY growth.
- EPS of 0.26 exceeds estimates by 0.02, with 30.00% YoY growth.
Analysts project revenue of ... Upgrade
